Cryptogenic organizing pneumonia medical therapy: Difference between revisions
Jump to navigation
Jump to search
| Line 9: | Line 9: | ||
*The mainstay of the therapy is pharmacotherapy. | *The mainstay of the therapy is pharmacotherapy. | ||
*Corticosteroids are used as first-line treatment for patients with the symptomatic and progressive disease. | *Corticosteroids are used as first-line treatment for patients with the symptomatic and progressive disease. | ||
*For asymptomatic | *For asymptomatic mass lesions or nonprogressive disease, treatment is not required, observation is required till they become symptomatic. | ||
==References== | ==References== | ||
Revision as of 17:23, 27 February 2018
|
Cryptogenic Organizing Pneumonia Microchapters |
|
Differentiating Cryptogenic organizing pneumonia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Cryptogenic organizing pneumonia medical therapy On the Web |
|
American Roentgen Ray Society Images of Cryptogenic organizing pneumonia medical therapy |
|
Cryptogenic organizing pneumonia medical therapy in the news |
|
Directions to Hospitals Treating Cryptogenic organizing pneumonitis |
|
Risk calculators and risk factors for Cryptogenic organizing pneumonia medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]
Overview
Medical Therapy
- The mainstay of the therapy is pharmacotherapy.
- Corticosteroids are used as first-line treatment for patients with the symptomatic and progressive disease.
- For asymptomatic mass lesions or nonprogressive disease, treatment is not required, observation is required till they become symptomatic.